Synthetic Biologics, Inc. (SYN)
Net Income Growth
64.25%
TTM · Period ending:
SYN Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported64.25%period ending
Latest reported64.25%period ending
SYN TTM Net Income YoY % (-98.98% → 64.25%)
Year-over-year change
High-resolution chart · PNG
SYN net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 64.2523% | |
| 14.8318% | |
| 8.9437% | |
| -73.3818% | |
| -5.4568% | |
| 9.4946% | |
| -12.7927% | |
| -24.9063% | |
| -38.7063% | |
| -79.1235% | |
| -79.0908% | |
| -66.4899% | |
| -42.0791% | |
| -0.3522% | |
| 29.4372% | |
| 34.8356% | |
| 34.3723% | |
| 27.7908% | |
| -1.4033% | |
| -1.3254% | |
| -14.492% | |
| -108.852% | |
| 4.724% | |
| 0.5532% | |
| 11.9093% | |
| 64.0014% | |
| 18.1951% | |
| 23.9562% | |
| 44.3295% | |
| 43.1209% | |
| 47.9946% | |
| 54.3956% | |
| 37.6843% | |
| 8.5969% | |
| 8.2631% | |
| -49.1803% | |
| -121.0726% | |
| -123.8419% | |
| -133.7733% | |
| -103.2311% | |
| -60.6235% | |
| 13.0512% | |
| 14.6093% | |
| 23.0382% | |
| 27.8357% | |
| -146.2419% | |
| -154.5467% | |
| -152.6479% | |
| -109.449% | |
| -40.3047% | |
| -34.4597% | |
| -154.8857% | |
| -376.2269% | |
| -198.5572% | |
| -196.0457% | |
| 24.1937% | |
| 54.1576% | |
| 44.6988% | |
| 57.397% | |
| 29.1077% | |
| 48.1941% | |
| 62.6009% | |
| 57.2376% | |
| 48.3938% | |
| 27.1657% | |
| 12.7037% | |
| -16.4802% | |
| -45.8194% | |
| -114.3735% | |
| -1,931.2388% | |
| -1,512.6814% | |
| -146.8654% | |
| -115.0291% | |
| -101.1349% | |
| 634.7646% | |
| 379.3036% | |
| 209.407% | |
| 42.3071% | |
| 9.089% | |
| -32.0595% | |
| -75.902% | |
| -87.4181% | |
| -64.4784% | |
| 53.8132% | |
| 61.5217% | |
| 66.8216% | |
| 67.0391% | |
| -242.0359% | |
| -209.2226% | |
| -1.3822% | |
| 5.9958% | |
| 73.4375% | |
| 70% | |
| -92.3077% | |
| -95.7895% | |
| -90.099% | |
| -93.8776% | |
| -12.3457% | |
| -33.8028% | |
| -44.2857% |